Related Experiment Videos
Localized unresectable pancreatic cancer.
A D Treurniet-Donker1, M J van Mierlo, W L van Putten
1Dr Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
International Journal of Radiation Oncology, Biology, Physics
|January 1, 1990
Summary
This study shows that combining radiation therapy and 5-fluorouracil chemotherapy is a viable treatment for unresectable pancreatic cancer, offering significant survival benefits for patients.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Oncology
Background:
- Pancreatic cancer, particularly unresectable localized forms, presents a significant therapeutic challenge.
- Effective treatment strategies for improving patient survival are urgently needed.
Purpose of the Study:
- To evaluate the efficacy and safety of a combined treatment protocol for unresectable localized pancreatic cancer.
- To determine survival outcomes and treatment-related toxicity.
Main Methods:
- A cohort of 40 patients with unresectable localized pancreatic cancer received split-course external radiation therapy (50 Gy) combined with intravenous 5-fluorouracil (375 mg/m2/day for 4 days per course).
Main Results:
- The combined treatment demonstrated no mortality and moderate morbidity.
- Median survival was 9 months.
- A notable 3-year survival rate of six patients and a 5-year survival rate of three patients were observed.
Conclusions:
- The combined modality of radiation therapy and 5-fluorouracil is a promising treatment for unresectable localized pancreatic cancer.
- These results support its consideration as a standard treatment and for comparison in future Phase III clinical trials.